Loprox and Lamisil drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Loprox (ciclopirox) and Lamisil (terbinafine hydrochloride). Common drug interactions include beta 2 microglobulin increased among females and body temperature decreased among males.
The phase IV clinical study analyzes what interactions people have when they take Loprox and Lamisil. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.
What is Loprox?
Loprox has active ingredients of ciclopirox. eHealthMe is studying from 618 Loprox users. Check the latest studies of Loprox.
What is Lamisil?
Lamisil has active ingredients of terbinafine hydrochloride. It is often used in pulmonary aspergilloma (mycetoma). eHealthMe is studying from 14,080 Lamisil users. Check the latest studies of Lamisil.
49 people who take Loprox and Lamisil together, and have interactions are studied.

What are the common drug interactions of Loprox and Lamisil, by gender? *:
female:
- Beta 2 microglobulin increased
- Blood calcium decreased
- Blood glucose increased
- Blood lactate dehydrogenase increased
- Blood triglycerides increased
- Body temperature increased
- Bone disorder
- Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
- Bone pain
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
male:
- Body temperature decreased
- Pruritus (severe itching of the skin)
- Skin exfoliation (removal of the oldest dead skin cells)
- Skin lesion
- Skin plaque (red, scaly patches to appear on the skin)
- Transient acantholytic dermatosis (a skin condition that causes the appearance of small, red spots on chest and back)
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Abdominal pain
- Injection site reaction
- Stress
What are the common drug interactions of Loprox and Lamisil, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Abdominal pain
- Diarrhoea
- Fall
- Hypoaesthesia (reduced sense of touch or sensation)
- Nausea (feeling of having an urge to vomit)
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Parosmia (distortion of the sense of smell, as in smelling odours that are not present)
- Pruritus (severe itching of the skin)
- Sweating increased (excess sweating)
- Tremor (trembling or shaking movements in one or more parts of your body)
30-39:
- Abdominal pain upper
- Acute respiratory distress syndrome
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anisocytosis (patient's red blood cells are of unequal size)
- Anxiety
- Asthenia (weakness)
- Back pain
- Beta 2 microglobulin increased
- Blood calcium decreased
- Blood glucose increased
40-49:
- Arthralgia (joint pain)
- Dysphagia (a condition in which swallowing is difficult or painful)
- Emotional distress
- Gait disturbance
- Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
- Oedema peripheral (superficial swelling)
- Osteoarthritis (a joint disease caused by cartilage loss in a joint)
- Pyrexia (fever)
- Abdominal discomfort
- Abdominal distension
50-59:
- Phlebitis (inflammation of the walls of a vein)
- Urinary tract infection bacterial
- Wound
- Visual disturbance
- Vitreous detachment (a condition of the eye in which the vitreous humour separates from the retina)
- Vitreous floaters (spots before the eyes)
- Body temperature decreased
- Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
- Discomfort
- Drug ineffective
60+:
- Malaise (a feeling of general discomfort or uneasiness)
- Abscess (pus)
- Constipation
- Death
- Inflammation
- Lethargy (tiredness)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Nasopharyngitis (inflammation of the nasopharynx)
- Pain of skin
- Abdominal distension
What are the existing conditions these people have? *
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 11 people, 22.45%
- Urticaria (rash of round, red welts on the skin that itch intensely): 8 people, 16.33%
- Joint Injury: 7 people, 14.29%
- Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 4 people, 8.16%
- Nail Tinea (fungal infection of nail): 3 people, 6.12%
* Approximation only. Some reports may have incomplete information.
Do you take Loprox and Lamisil?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Loprox and Lamisil:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Loprox:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lamisil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Loprox and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lamisil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on ciclopirox and terbinafine hydrochloride (the active ingredients of Loprox and Lamisil, respectively), and Loprox and Lamisil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Tramadol and Polaramine - a second ago
- Drug interactions of Pletal and Symmetrel - 2 seconds ago
- Could Arava cause Alanine Aminotransferase Abnormal? - 6 seconds ago
- Could Methotrexate cause Feeling Abnormal? - 14 seconds ago
- Could Methotrexate cause Sinusitis - Chronic? - 36 seconds ago
- Could Simbrinza cause Visual Impairment? - 39 seconds ago
- Could Methotrexate cause Hepatitis E Antibody Positive? - 39 seconds ago
- Could Sildenafil Citrate cause Nasopharyngitis? - 42 seconds ago
- Could Elavil cause Micturition Urgency? - a minute ago
- Could Elavil cause Aphthous Stomatitis? - a minute ago